Figure 1.
Genomic alterations across breast cancers. (A) Frequency of genomic alteration (mutation and copy number variation) in the 147 breast cancer driver genes across the TCGA pancancer breast cancer dataset (n = 1033); and stratified by oestrogen receptor (ER) status (in magnified plot): ER positive, n = 795; ER negative, n = 238. Top ten most frequently mutated genes in (B) Invasive Carcinoma-No Special Type (IC-NST) [15]; (C) Invasive Lobular Carcinoma (ILC) [15]; and, (D) Metaplastic breast cancer [36,37,38].
